Popular Articles
Cellulite Cream

Government Of Canada Approves A New Of Medical Isotopes
The Honourable Leona Aglukkaq, Minister of Health, announced the approval of a new of the medical isotope Iodine-131 (I-131) to treat thyroid cancer in Canada.
generic viagra online
Evidence That Cognitive Therapy Is Of No Value In Schizophrenia
Research co-led by an academic at the University of Hertfordshire, concludes that Cognitive Behavioural Therapy (CBT) is of no value in schizophrenia and has limited effect on depression. Professor Keith Laws, at the University"s School of Psychology, is one of the lead authors on a paper entitled: Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials, which has just been published online in the journal Psychological Medicine. The paper reviews the use of CBT in schizophrenia, bipolar disorder and major depression.
News of the day
National Public Health Organizations Brief Capitol Hill On H1N1
The recent H1N1 flu outbreak served as a genuine test of our national public health system"s ability to respond to an emerging public health threat and experts are cautioning that a more severe outbreak could occur in the fall of 2009. Leaders from some of the nation"s foremost public health and medical associations will conduct a briefing for staff members from House and Senate offices on Thursday, May 21, 2009. Speakers will focus on the status of the current public health workforce and efforts needed to sustain workforce capacity to respond to emerging infectious diseases.
Oncology

Cognitive Impairment Associated With Reduced Survival Among Both African-American And White Older Adults

Alzheimer"s disease and its precursor, mild cognitive impairment, appear to be associated with an increased risk of death among both white and African American older adults, according to a report in the June issue of Archives of Neurology, one of the JAMA/Archives journals. Alzheimer"s disease reduces life expectancy and has emerged as a leading cause of death in the United States, according to background information in the article. "Data from two national surveys suggest that life expectancy among patients with Alzheimer"s disease may be greater for African Americans than for whites," the authors write. "However, not all surveys have reported this difference. Furthermore, in these surveys, the diagnosis of Alzheimer"s disease is not based on a uniform clinical evaluation but derived from medical records, increasing the likelihood of substantial variation in the quality of diagnostic classifications." Robert S. Wilson, Ph.D., and colleagues at Rush University Medical Center, Chicago, studied 1,715 older adults (average age 80.1, 52.5 percent African American) from four adjacent neighborhoods in Chicago. Each participant had a clinical evaluation that included medical history, a neurological examination and cognitive (thinking, learning and memory) function testing. Based on these evaluations, an experienced physician diagnosed 296 (17.3 percent) of the participants with Alzheimer"s disease, 597 (34.8 percent) with mild cognitive impairment and 20 (1.2 percent) with other forms of dementia, while 802 (46.8 percent) had no cognitive impairment. During up to 10 years of follow-up (average observation period, 4.7 years) 634 individuals died (37 percent), including 25.8 percent of those without cognitive impairment, 40.4 percent of those with mild cognitive impairment, 59.1 percent of those with Alzheimer"s disease and 60 percent of those with other forms of dementia. "Compared with people without cognitive impairment, risk of death was increased by about 50 percent among those with mild cognitive impairment and was nearly three-fold greater among those with Alzheimer"s disease," the authors write. "These effects were seen among African Americans and whites and did not differ by race." Among individuals with mild cognitive impairment, risk of death increased as cognitive impairment became more severe, another association that did not differ by race. A similar association between disease severity and survival was seen among patients with Alzheimer"s disease, although that effect was slightly stronger for African Americans than for whites. "Overall, these results do not suggest strong racial differences in survival for persons with mild cognitive impairment and Alzheimer"s disease," the authors conclude. Arch Neurol. 2009;66[6]:767-772. Archives of Neurology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):